Imidazopyridinyl-benzamide anti-cancer agents

A compound of Formula V

• or a pharmaceutically acceptable salt thereof wherein
• R2 is hydrogen or lower alkyl;
• R3 is chosen from
• lower alkyl substituted with a hydroxyl or a phosphate ester thereof and
• lower alkyl substituted with an amino group wherein the amino group is further substituted with a group —CORb wherein Rb is chosen from hydrogen, C1-C6 alkyl, aryl, and heteroaryl;
• R11 is hydrogen, cyano, nitro, or halo;
• R12 is lower alkoxy or 2,2,2-trifluoro-1-methyl-ethoxy;
• R13 is hydrogen, alkyl-, alkoxy, halo, hydroxyl, nitro, cyano, or amino;
• R14 is imidazo[1,2-a]pyridin-2-yl optionally substituted with one or two groups chosen from lower alkyl, halo, acyl, trifluoromethyl, aminomethyl, and lower alkyl substituted with hydroxy;
• and
• R15 is chosen from hydrogen, halo, hydroxyl, and lower alkyl.